Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
Part of paid clinical trials in Fremont, California.
- Sponsor
- MicroPort Orthopedics Inc.
- Study ID
- NCT04816773
- Status
- Enrolling By Invitation
Conditions
- Arthritis Knee
- Avascular Necrosis
- Joint Diseases
- Osteoarthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- EVOLUTION® NitrX™ — DEVICEEVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
Study Details
MicroPort Orthopedics Inc. (MPO) plans to market the EVOLUTION® NitrX™ Non-Porous Keeled Tibia and EVOLUTION® NitrX™ CS/CR Non-Porous Femur with the EVOLUTION® Cruciate Sacrificing (CS) Tibial Insert globally, including in the European Union (EU). MPO is conducting this post market clinical follow-up (PMCF) study to evaluate the safety and effectiveness of the EVOLUTION® NitrX™ Non-Porous Keeled Tibia and EVOLUTION® NitrX™ CS/CR Non-Porous Femur. These components are used along with the EVOLUTION® Cruciate Sacrificing (CS) Tibial Insert components that is marketed in the European Union (EU). This type of data collection is required by regulatory authorities for all TKA devices that do not have medium to long-term clinical evidence available.
Key Dates
- Start date
- Jan 27, 2022
- Status verified
- Mar 2024
- Primary completion
- Aug 31, 2034
- Completion
- Jan 31, 2035
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Newly or previously implanted patientsMulticenter, non-interventional prospective follow-up of newly or previously implanted subjects. Previously implanted subjects must be enrolled within 14 months of the study index surgery. Single study group with either newly or previously implanted patients with all EVOLUTION® NitrX™ components: Non-Porous Keeled Tibia, CS/CR Non-Porous Femur component, and EVOLUTION® MP CS tibial insert
Primary Outcome Measure
Component Survivorship of the EVOLUTION® NitrX™ Non-Porous Keeled Tibia [ Time Frame: 10 years post-operative ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sah Orthopaedic Associates | Fremont | California | 94538 | - |
Find similar trials in Fremont, CA
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsNot Yet Recruiting · R3 Stem Cell · Encino, California
- Adipose-Derived Biocellular Regenerative Therapy for OsteoarthritisRecruiting · Healeon Medical Inc · Valencia, California
- G7 Freedom Constrained Vivacit-E LinersEnrolling By Invitation · Zimmer Biomet · Birmingham, Alabama